214 related articles for article (PubMed ID: 24896044)
21. The clinical utility of lenalidomide in multiple myeloma and myelodysplastic syndromes.
Bonkowski J; Vermeulen LC; Kolesar JM
J Oncol Pharm Pract; 2010 Dec; 16(4):223-32. PubMed ID: 19910392
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide gives food for thought in multiple myeloma.
Burton A
Lancet Oncol; 2006 Apr; 7(4):283-4. PubMed ID: 16598872
[No Abstract] [Full Text] [Related]
23. Thalidomide and thrombosis.
Mehta P
Clin Adv Hematol Oncol; 2003 Aug; 1(8):464-5. PubMed ID: 16258433
[No Abstract] [Full Text] [Related]
24. The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience.
Sriskandarajah P; Pawlyn C; Mohammed K; Dearden CE; Davies FE; Morgan GJ; Boyd KD; Kaiser MF
Leuk Lymphoma; 2017 Feb; 58(2):494-497. PubMed ID: 27439571
[No Abstract] [Full Text] [Related]
25. Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.
Chanan-Khan AA; San Miguel JF; Jagannath S; Ludwig H; Dimopoulos MA
Clin Cancer Res; 2012 Apr; 18(8):2145-63. PubMed ID: 22328563
[TBL] [Abstract][Full Text] [Related]
26. [Thalidomide for the treatment of refractory multiple myeloma].
Kakimoto T; Hattori Y; Okamoto S
Rinsho Ketsueki; 2002 May; 43(5):345-8. PubMed ID: 12096483
[No Abstract] [Full Text] [Related]
27. Thalidomide in multiple myeloma.
Rajkumar SV
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 13):11-6. PubMed ID: 11204667
[TBL] [Abstract][Full Text] [Related]
28. [Thalidomide: mechanisms of action and new insights in hematology].
Leleu X; Micol JB; Guieze R; Berthon C; Kuhnovsky F; Terriou L; Moreau AS; Yakoub-Agha I; Bauters F; Facon T
Rev Med Interne; 2005 Feb; 26(2):119-27. PubMed ID: 15710258
[TBL] [Abstract][Full Text] [Related]
29. Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone.
Montagnese F; Portaro S; Musumeci O; Migliorato A; Moggio M; Fagiolari G; Rodolico C
Muscle Nerve; 2015 Jun; 51(6):934-5. PubMed ID: 25524603
[No Abstract] [Full Text] [Related]
30. Trials investigate first-line thalidomide in multiple myeloma.
Owen OG
Lancet Oncol; 2005 Jan; 6(1):6. PubMed ID: 15672486
[No Abstract] [Full Text] [Related]
31. Thalidomide in multiple myeloma: current status and future prospects.
Cavenagh JD; Oakervee H;
Br J Haematol; 2003 Jan; 120(1):18-26. PubMed ID: 12492572
[No Abstract] [Full Text] [Related]
32. Spotlight on lenalidomide in relapsed or refractory multiple myeloma.
Scott LJ; Lyseng-Williamson KA
BioDrugs; 2011 Oct; 25(5):333-7. PubMed ID: 21942918
[TBL] [Abstract][Full Text] [Related]
33. [Lenalidomide in hematological malignancies---review].
Jin X; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):205-9. PubMed ID: 22391198
[TBL] [Abstract][Full Text] [Related]
34. Impact of lenalidomide on immune functions in the setting of maintenance therapy for multiple myeloma.
Brissot E; Clavert A; Blin N; Roland V; Guillaume T; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Gaugler B; Moreau P; Mohty M
Leukemia; 2015 Oct; 29(10):2098-100. PubMed ID: 25748683
[No Abstract] [Full Text] [Related]
35. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
Rajkumar SV; Witzig TE
Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients.
Amraoui K; Belhadj K; Maître B; Jannière-Nartey C; Dupuis J
Eur Respir Rev; 2013 Mar; 22(127):93-5. PubMed ID: 23457172
[No Abstract] [Full Text] [Related]
37. Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myeloma.
Mark TM; Coleman M; Niesvizky R
Leuk Res; 2014 May; 38(5):517-24. PubMed ID: 24690110
[TBL] [Abstract][Full Text] [Related]
38. Treatment of multiple myeloma: thalidomide-, bortezomib-, and lenalidomide-induced peripheral neuropathy.
Koeppen S
Oncol Res Treat; 2014; 37(9):506-13. PubMed ID: 25231692
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma.
Suppiah R; Srkalovic JG; Hussein MA
Clin Lymphoma Myeloma; 2006 Jan; 6(4):301-5. PubMed ID: 16507207
[TBL] [Abstract][Full Text] [Related]
40. A rosette by any other name..
O'Malley DP
Arch Pathol Lab Med; 2003 Aug; 127(8):1053. PubMed ID: 12873189
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
